The main office of represented VC is situated in the Chicago. The fund was located in North America if to be more exact in United States.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Kythera Biopharmaceuticals, FibroGen, Cogentus Pharmaceuticals The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Pharmaceutical, Medical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the Apothecary Capital, startups are often financed by Prospect Venture Partners, Versant Ventures, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Prospect Venture Partners, Versant Ventures, Frazier Healthcare Partners. In the next rounds fund is usually obtained by Versant Ventures, Temasek Holdings, Skyline Ventures.
The high activity for fund was in 2007. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Apothecary Capital works on 51 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2014.
Related Funds
Funds with similar focus
Fund Name | Location |
Anzhuoxin Venture Capital | China, Guangdong Province, Huizhou |
Avlar BioVentures | Cambridgeshire, Madingley, United Kingdom |
Greenhouse Capital Partners | California, Sausalito, United States |
Manitou Ventures | California, San Francisco, United States |
MegaChips | Japan, Osaka, Osaka Prefecture |
Raised In Space Enterprises | California, Santa Monica, United States |
Rhiza Capital / Sunshine Coast Venture Partners | - |
Siemens Financial Services | - |
Zamagias Properties Inc. | Pennsylvania, Pittsburgh, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
Kythera Biopharmaceuticals | $30M | 19 May 2008 | California, United States | ||
Cogentus Pharmaceuticals | $62M | 21 Dec 2007 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
Kythera Biopharmaceuticals | $30M | 19 May 2008 | California, United States | ||
Cogentus Pharmaceuticals | $62M | 21 Dec 2007 | California, United States |